Deutsch

M65.1: Circulating cancer stem cells as a new predictive biomarker for treatment response and metastasis in pancreatic cancer

Dokumentation 2013–2019

Projektleiter:
Herrn Dr. med. Patrick Christian Hermann

Marbachstraße 8
81369 München

Projekttitel:

Circulating cancer stem cells as a new predictive biomarker for treatment response and metastasis in pancreatic cancer

Projektdauer:

12/2013 – 2018/2019

Veröffentlichungen:
  • Detection of Hot-Spot Mutations in Circulating Cell-Free DNA  From Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas
    Andreas W. Berger, Daniel Schwerdel, Ivan G. Costa, Thilo Hackert, Oliver Strobel, Sandra Lam, Thomas F. Barth, Bernd Schröppel, Alexander  Meining, Markus W. Büchler, Martin Zenke, Patrick C. Hermann, Thomas Seufferlein and Alexander Kleger Gastroenterology 2016;151:267-270

  • Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness
    Lukas Perkhofer, Karolin Walter, Ivan G. Costa, Maria C. Romero Carrasco, Tim Eiseler, Susanne Hafner, Felicitas Genze, Martin Zenke, Wendy Bergmann, Anett Illing, Meike Hohwieler, Ralf Köhntop, Qiong Lin, Karl-Heinz Holzmann, Thomas Seufferlein, Martin Wagner, Stefan Liebau, Patrick C. Hermann, Alexander Kleger, Martin Müller
    Stem Cell Research 17 (2016) 367-378

  • The ever-Changing landscape of pancreatic cancer stem cells
    Patricia Sancho, Sonia Alcala, Valentyn Usachov, Patrick C. Hermann, Bruno Sainz Jr.
    Pancreatology 16 (2016) 489-496